These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15682630)

  • 21. Labor market, financial, insurance and disability outcomes among near elderly Americans with depression and pain.
    Tian H; Robinson RL; Sturm R
    J Ment Health Policy Econ; 2005 Dec; 8(4):219-28. PubMed ID: 16385147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in prescription drug use in HMO and self-insured health plans.
    Wallack SS; Thomas CP; Martin TC; Ryan A
    Med Care Res Rev; 2007 Feb; 64(1):98-116. PubMed ID: 17213460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescription drug benefit design: the building blocks and their impact on cost.
    Kopenski F
    Benefits Q; 2008; 24(4):7-11. PubMed ID: 19048742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status.
    Boudreau DM; Doescher MP; Saver BG; Jackson JE; Fishman PA
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):877-84. PubMed ID: 15931653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
    Mager DE; Cox ER
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.
    Landsman PB; Yu W; Liu X; Teutsch SM; Berger ML
    Am J Manag Care; 2005 Oct; 11(10):621-8. PubMed ID: 16232003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
    Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
    Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of generic-only drug benefits on seniors' medication use and financial burden.
    Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
    Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating benefits decision making.
    Lucas L; Kairey M; Markus LH
    Benefits Q; 2005; 21(2):7-11. PubMed ID: 15977747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.
    Goldman DP; Joyce GF; Karaca-Mandic P
    Am J Manag Care; 2006 Jan; 12(1):21-8. PubMed ID: 16402885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical counseling and medication adherence monitoring: an essential component of any drug benefit program.
    Christensen DB
    Med Interface; 1996 Aug; 9(8):76-9. PubMed ID: 10159580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumer understanding and satisfaction associated with a 3-tier prescription drug benefit.
    Olson BM; Malone DC; Zachary WM; Coons SJ
    J Manag Care Pharm; 2005; 11(6):480-92. PubMed ID: 15998165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescribing a pharmacy benefits manager. The shadowlands of PBMs. Seek out the experts to navigate the gray territory of drug-benefits managing.
    Becker C
    Mod Healthc; 2004 Nov; 34(45):S4. PubMed ID: 15560637
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictors of satisfaction of health plan members with prescription drug benefits.
    Motheral BR; Heinle SM
    Am J Health Syst Pharm; 2004 May; 61(10):1007-14. PubMed ID: 15160776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of positive psychological capital on employee well-being over time.
    Avey JB; Luthans F; Smith RM; Palmer NF
    J Occup Health Psychol; 2010 Jan; 15(1):17-28. PubMed ID: 20063956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consumers' lack of awareness on issues pertaining to their prescription drug coverage.
    Desselle SP
    J Health Soc Policy; 2003; 17(3):21-39. PubMed ID: 17824584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.